Pharmacological targeting of β-catenin in normal karyotype acute myeloid leukemia blasts

• Elizabeth A. Griffiths,
• Michelle C. Golding,
• Pragya Srivastava,
• Benjamin J. Povinelli,
• Smitha R. James,
• Laurie A. Ford,
• Meir Wetzler,
• Eunice S. Wang,
• Michael J. Nemeth

Affiliations

Elizabeth A. Griffiths

Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA;Department of Pharmacology and Experimental Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA;Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY, USA

Michelle C. Golding

Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY, USA

Pragya Srivastava

Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA

Benjamin J. Povinelli

Department of Molecular and Cellular Biology, Roswell Park Cancer Institute, Buffalo, NY, USA

Smitha R. James

Department of Pharmacology and Experimental Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA

Laurie A. Ford

Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA

Meir Wetzler

Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA

Eunice S. Wang

Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA

Michael J. Nemeth

Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA;Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY, USA